We are proud to announce that the NHS is set to trial a “personalised medicine” DNA test developed by Genomics, a biotech company founded and run by St Anne’s Honorary Fellow, Professor Sir Peter Donnelly. The goal is to use the test to identify those whose genes make them more vulnerable to strokes and heart …
The 2021 Recognition of Distinction Exercise is now open for applications. All those employed by the University in academic or senior research roles are eligible to apply, as are other University employees who are making a significant and sustained academic contribution to the University. Individuals not employed by the University, but who are employed on …
We are delighted to announce that Professor Cecilia Lindgren, St Anne’s Senior Research Fellow in Medical Sciences, has been appointed as the new Director of the University of Oxford’s Big Data Institute. The availability of biomedical information, also known as ‘big data’, is increasing rapidly. The analysis of this data provides an opportunity for transforming the …
Lionheart Ventures is a global, seed-stage venture capital firm investing in companies that make humanity more resilient. Founded by St Anne’s alum David Langer (Mathematics, 2007) and based in Silicon Valley, Lionheart’s mission is to ensure humanity’s existential security for a thriving and biodiverse future. Their current investment focus is into deep technology start-ups in …
Daniele Nunziata Please briefly introduce yourself and what you are currently doing My name is Daniele Nunziata, I am a Stipendiary Lecturer in English Literature and I teach Victorian and modern literatures from 1830 to the present. This involves tutoring two of the Prelims Papers. The texts included in these classes span from Victorian life-writers …